COVID-19 Commentary from India: Lockdown Saga

India is a country of countries. Don’t get surprised. It is made of 28 States and 8 Union Territories, a total of 36 entities. Each of these are different in culture, culinary, language, outfit, style of living, weather and health systems. Each one of these are like different countries. However, each one is tightly bonded with each other for several reasons. We truly represent ‘unity within diversity’. COVID-19 has perhaps further brought all of them together to fight with this deadly disease.

Each State & UT followed directives of the Central Government for the lockdown. India has done better so far in containing the virus compared to several countries but lagged behind from many. We have huge challenge of massive population with densely populated geographical area. Let’s have a look at the numbers since this most contagious microorganism named SARS-CoV-2 causing COVID-19 disease has surfaced officially in India. Not the mention that political grounds were not easy for the Central Government though Epidemic Diseases Act, 1897 came handy and State governments and political parties did not have any option but to follow directives of the Central Government in the best interest of its citizens.  

30 January 2020, India reported its first confirmed case of COVID-19 in Kerala, one of the State in down South, with travel history to Wuhan at the time when the world has 7818 confirmed cases. By 3 February, India had three cases. All three cases were in Kerala and they were students who had returned from Wuhan, China. Kerala did well and perhaps their preparedness during Nipah outbreak came handy.

We were perhaps a silent spectator during February. Not much attention paid, may be no one knew the nature and behaviour of SARS-CoV-2 and did not expect if it was more serious issue than the one in ‘Contagion’. This novel coronavirus was at his work quietly at all the time. We the human, the most intelligent species known to exist on the earth, were busy with our business as we never imagine that sky is going to fall and this coronavirus will put the world under unprecedented series of ‘lockdowns’. The transmission started escalating during March, after several cases were reported all over the country, most of which were linked to people with a travel history to affected countries. I talk to myself and said ‘we could have paid serious attention on 30 January when the first case was found’. I personally feel that we could have started restrictions and a close monitoring that time and could have closed our skies to stop importing the virus. I know that it was not an easy decision to take in view of several factors including trade and economy but perhaps that was warranted. Might be controlling this virus would have been easy and at a less cost to us compared to what we had paid and may continue paying now. This is just my hypothesis and I am sure that our leadership did the best by doing what they were advised by the system as per the limited information available at that point in time.

2 March: Two more positive cases: a 45-year-old man in Delhi who had travelled back from Italy and a 24-year-old engineer in Hyderabad who had a travel history with the United Arab Emirates. In addition, an Italian citizen in Jaipur, who was earlier tested negative, tested positive, making it a total of six confirmed cases in the country. Officials of the Government of Telangana stated that 36 people who had been in contact with the Hyderabad engineer had developed coronavirus symptoms.

4 March, twenty-two new cases came to light; wife of the already confirmed Italian patient in Jaipur has been confirmed for COVID-19. 14 Italians and one Indian, who were part of the team of the Jaipur COVID-19 confirmed case, are also initially confirmed positive for COVID-19. Six family members at Agra, who were family members of the COVID-19 confirmed case from Delhi, were confirmed for COVID-19. These were undoubtedly excellent examples of how contagious this coronavirus is and tell us the importance of testing, contact tracing and isolation to prevent further transmission.

11 March, globally, there were 118319 confirmed cases with 4292 deaths; India had a total of 60 confirmed cases with no death. 12 March, A 76-year-old man who had returned from Saudi Arabia became the first victim of the virus in the country. He was a known case of hypertension and asthma, linking the fatality with comorbid conditions.

At this stage, the important question to ask was whether we started sufficient testing?  As per a study published in Indian Journal of Medical Research, 29 May 2020, there were about 250 individuals being tested around this time.

 

Lockdown 1.0

24th March, we had the first nationwide lockdown (1.0), our very first experience, announced from 24 March midnight for 21 days. It was the beginning of an era wherein some countries were trying to learn and adopt containment strategies from other countries and some were experimenting as well.

A Sikh preacher that returned from travel to Italy and Germany, carrying the virus, turned into “super spreader” by attending a Sikh festival in Anandpur Sahib during 10-12 March. Twenty-seven COVID-19 cases were traced back to him. Over 40,000 people in 20 villages in Punjab were quarantined on 27 March to contain the spread.

31st March, a Tablighi Jamaat religious congregation event that took place in Delhi in early March emerged as a new virus hotspot after numerous cases across the country were traced back to the event. Over 9,000 missionaries may have attended the congregation, with the majority being from various states of India, and 960 attendees from 40 foreign countries. According to Ministry of Health and Family welfare, 4,291 out of 14,378 confirmed cases were linked to this event in 23 Indian states and union territories as on 18 April.

 

Lockdown 2.0

20 April, the second nationwide lockdown (2.0) rolled out till 3 May, with conditional easing of restrictions in low risk areas that have been able to contain the virus.

Confirmed cases in India crossed 100 on 15 March, 1000 on 28 March, 5000 on 7 April, 10000 on 14 April, 20000 on 22 April, 30000 on 29 April, with roughly a doubling time of 7 days. Lockdown was working! Super spreaders were at work silently as well.

2 May, in Punjab, 609 pilgrims from around 4000 pilgrims who returned from Hazur Sahib in Nanded, Maharashtra tested positive. 27 bus drivers and conductors who took stranded pilgrims back to the state also tested positive. As of 5 May, 969 pilgrims have tested positive from around 2,900 pilgrims tested.

Contact tracing, testing and isolation, the strategy suggested by WHO and adopted by most of the countries was also adopted by India. As per a study published in Indian Journal of Medical Research on 29 May 2020, testing increased from about 250 individuals per day in the beginning of March to 50,000 per day by the end of April 2020. This represented a 200-fold increase in testing over eight weeks. The cumulative frequency of testing was 770 individuals per million population. COVID-19 dedicated hospitals both in government and private were identified by governments in all States. No doubt that hospitals have risen to the occasion.

Lockdown 3.0

4 May, the third nationwide lockdown (3.0) was put into action until 17 May. On 5 May, the Koyambedu (Tamil Nadu) wholesale market one of the largest wholesale vegetable markets in the country has become a super spreader of SARS-Cov-2. Almost all the 122 positive cases reported in Cuddalore can be traced back to Koyambedu.  In Rajasthan, the Jaipur municipal corporation identified 10 fruit and vegetable vendors as super spreaders after they infected about 150 persons in the city. Nineteen super spreaders including vegetable vendors, milk vendors and grocery shop workers, became the carrier for the virus in 30 new localities in Ahmedabad, which accounts for about 70% of the total cases in the State of Gujarat that has 8194 on 11 May. In Odisha’s Bhubaneswar, a food delivery boy was identified as positive. In Lucknow, eight persons were infected from a vegetable vendor. In Haryana’s Jhajjar, which had no case till April 24, 11 vegetable sellers who visited Delhi’s largest fruit and vegetable market tested positive for the ‘contagion’ days later.

Lockdown 4.0

18 May, beginning of lockdown 4.0, India surpassed China at 90648 with total deaths of 2871 at doubling time of 12 days. India reached a landmark by performing 100000 tests in one day.

Interestingly, On 11 March, there were total 118319 cases globally which are very close to 118226  (about 2.3% of global cases) in India on 22 May when the world is sitting at 5190496.

We crossed 60000 cases on 10 May and 120000 on 22 May. If anyone interested in doubling time, it was 7 days on 14 April and 12 days on 22 May. Hopefully, strategy was working!

Countdown Begins with Lockdown 5.0 and Unlock 1.0

Ministry of Home Affairs has issued the order on 30 May about extending Lockdown (Lockdown 5.0) in the containment zones upto 30 June 2020, and to re-open the prohibited activities outside the containment zones (Unlock 1.0).

We have a huge challenge ahead of us as number of cases are rising and restrictions are easing out. Our Hon’ble Prime Minister laid great emphasis on ‘social distancing’ through the slogan ‘do gaj ki doori- bahut zaroori (a distance of two yards is very important). It is hard to predict what is going to happen after easing out movements, restrictions and opening of businesses. At the time of closing this blog (10.30 AM IST on 31 May 2020), India had 182143 confirmed cases with 86984 recovered & 5164 deaths, and Maharashtra leading with highest cases at 65168 (reported by ‘Aarogya Setu’, an app developed by Government of India with 118.2 million users). A total of 3737027 samples were tested (at 9 AM IST, 31 May 2020 on icmr.gov.in).

 

In last three months, India has achieved tremendously- everyone had done their bits- salute to all those who are at the front line and also to those supporting from the backend to make a sustainable emergency response system. As per the testing capacity report from ICMR, in January 2020, India had only one laboratory testing for COVID-19, at the Indian Council of Medical Research’s National Institute of Virology, Pune. As on 21 May, there were 555 laboratories across the country, performing molecular tests for diagnosis of COVID-19 – an unparalleled achievement in the history of the Indian health system.

The role of strong leadership at all levels driving down from Hon’ble Prime Minister, health system which responded to emergency, an implemented quality management system and infection prevention & control programme in the hospitals to contain the transmission of SARS-CoV-2 amongst healthcare workers and provide appropriate care to patients, has helped respond to this crisis. 

Let’s wait and watch how Unlock 1.0 would impact the scenario. Tough time ahead however, we Indian are well known to win a fight.

      

Dr. B.K. Rana

Chief Executive Officer, Quality & Accreditation Institute (QAI) (www.qai.org.in)

ISQua Board Member

Recent Blog Articles

Stay in Touch

We bring you the latest research, expert opinions, and industry updates in healthcare safety and quality – so you’re always in the know.

Follow us on social media

Nourhan Kawtharani


Nourhan, a quality and safety coordinator with eight years of experience in ambulatory healthcare in Lebanon, aims to deepen her understanding of the systemic and holistic approach to healthcare through this fellowship.

She aims to identify gaps and develop tailored interventions that address specific contexts rather than applying general solutions. Engaging with diverse professionals and perspectives during this educational journey will expand the application of these concepts across different cultural settings.

Nourhan emphasizes the importance of promoting a culture of continuous learning and improvement within healthcare institutions, considering it a vital leadership responsibility to integrate quality and safety initiatives into the organizational culture.

Nourhan's commitment to patient safety and quality management includes sourcing practical resources and transforming insights into actionable knowledge to drive continued progress in healthcare practices and outcomes.

This will close in 0 seconds

Elom Otchi


Elom is passionate about improving quality of care and patient safety outcomes.

In view of this, he has had the opportunity to work in various capacities with various organisations including AfIHQSA, WHO, UNICEF and others undertaking research, supporting the development of national quality policies and strategies, facilitating the establishment of quality governance systems across all the levels of the health sector and building capacity of national and sub-national quality leads/teams to institutionalize the practice of quality and patient safety across the continent.

He has also worked extensively across all levels of care in the health sector of Ghana, including leading the Quality & Patient Safety program in its largest teaching hospital.

I would like to use this Fellowship as a learning platform and an opportunity to acquire the requisite knowledge, skills and competencies to complement ongoing efforts by like-minded individuals and organizations to continuously advance improve the quality and patient safety in Ghana and the continent.

This will close in 0 seconds

Stephen Taiye Balogun


Stephen is a Senior Programme Officer at the Institute of Human Virology in Nigeria as well as Country Representative for Health Information for All (HIFA).

Stephen plans to use this opportunity to maximise his impact by championing the cause of patient safety and quality in Nigeria and across Africa.

Stephen says "Quality and safety is a major wheel through which universal healthcare coverage can be achieved. The goal is to be a bridge in the gap between the International Quality Improvement and Patient Safety community and my country to ensure rapid spread, adoption, implementation and practice."

We are looking forward to working with both Stephen and our 2020 winner Rhoda Kalondu over the next year.

This will close in 0 seconds

Dr Rhoda Kalondu


Rhoda is the Head of the Patient Safety Unit at Kenyatta Hospital in Nairobi and wants to use this Fellowship to learn how to establish a culture of safety and develop systems for assessment and analysis at her institution, and more widely. As well as this, Rhoda intends to develop and execute an intervention to improve patient safety in Kenyatta National Hospital.

It is one thing to institute measures and processes for improvement, but quite another to change the culture of an environment. Rhoda's ambition to lead others in this change inspired the panel.

This will close in 0 seconds

Dr Subhrojyoti Bhowmick


I am an MBBS graduate from Calcutta University with a Gold Medal in Gynecology & Obstetrics.

I have completed M.D in Pharmacology from IPGME& R, Kolkata and have over 12 years of experience in the field of Clinical Research, Pharmacovigilance and Medication management in Hospitals.

I have completed certification in Clinical Research Administration & Project Management from Stanford University, USA and in Patient Safety from Johns Hopkins University, USA.

I am an Assessor for National Accreditation Board for Hospitals & Health care providers (NABH), India assessing hospitals for medication safety and clinical quality standards and NABH Assessor for Ethics Committee Accreditation program in India as well.

I serve as the Chairperson, Institutional Ethics Committee of Health Point Hospital, Kolkata and am associated with 2 other Hospital ethics committees as a member.

I finished my Fellowship in Healthcare Quality from the International Society of Quality in Healthcare (ISQua) from Ireland in 2017.

I have published several research articles and have also authored a chapter on “Regulations governing Clinical Trial” in the book “Fundamentals of Clinical Trial & Research”.

I am a peer reviewer for prestigious international journals like the British Journal of Clinical Pharmacology, CNS Drugs and Drug Safety case reports.

I am the recipient of the UK Seth Oration Award for Best Clinical Pharmacology paper by the Indian Pharmacological Society in 2009 and the “Most promising Healthcare professional in Patient Safety in India” award by the Asian African Chamber of Commerce and Industry in October 2018.

Recently in April 2019, I received the Young Quality Achiever award by Consortium of Accredited Healthcare Organizations (CAHO), India for 2019 for my work in the field of medication safety and clinical research.

I have a keen interest in teaching and am visiting adjunct faculty of Pharmacology at KMC, Mangalore, India and for Healthcare technology at MAKAUT, Kolkata, India.

I was associated with Stanford University School of Medicine, in the USA as a Senior Clinical Research Associate from 2015 to 2017 and have certification in Biostatistics, Evidence-based Medicine and Medical Writing from Stanford University.

Currently, I am working as the Clinical Director of Academics, Medical Quality and Clinical Research at Peerless Hospital and B K Roy Research Centre, Kolkata.

I am very happy and thrilled to receive the prestigious ISQua Lucian Leape Patient safety Fellowship Award for 2019 and I look forward to honing my skills further in the field of healthcare quality and patient safety through my experiences during this fellowship.

I sincerely believe that successful completion of this fellowship will help me evolve as a more confident Patient safety leader in India who in turn can provide significant inputs on policy changes through NABH for the Indian healthcare system.

This will close in 0 seconds